Partial dopamine receptor agonists with different degrees of intrinsic activity within a series of 2-(4-aminophenyl)-N,N-dipropylethylamine derivatives: synthetic chemistry and structure-activity relationships

By Florvall L.   Hillegaart V.   Malmberg .   Wijkstrom A.   Ahlenius S.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 2, 1996-01 ,pp. : 133-142

Elsevier

Access to resources Recommend Favorite

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1068-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D1 receptor agonists as antiparkinson drugs

By Mailman R.B.   Nichols D.E.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 255-256

Elsevier

Access to resources Recommend Favorite

Identification and Characterization of a Novel Class of Atypical Dopamine Receptor Agonists

By Kuzhikandathil E.  

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2264-2275

Springer Publishing Company

Access to resources Recommend Favorite

Synthesis of 4-N,N-dialkylaminoethyl-2-indolones as potential dopamine agonists

By Namil A.   Benoit-Guyod M.   Leclerc G.  

European Journal of Medicinal Chemistry, Vol. 30, Iss. 12, 1995-01 ,pp. : 973-981

Elsevier

Access to resources Recommend Favorite